Align Technology (ALGN) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
4.0B
Gross Profit
2.8B
70.00%
Operating Income
671.8M
16.80%
Net Income
421.4M
10.54%
EPS (Diluted)
$5.62
Balance Sheet Metrics
Total Assets
6.2B
Total Liabilities
2.4B
Shareholders Equity
3.9B
Debt to Equity
0.61
Cash Flow Metrics
Operating Cash Flow
607.2M
Free Cash Flow
622.7M
Revenue & Profitability Trend
Align Technology Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.0B | 3.9B | 3.7B | 4.0B | 2.5B |
| Cost of Goods Sold | 1.2B | 1.2B | 1.1B | 1.0B | 708.7M |
| Gross Profit | 2.8B | 2.7B | 2.6B | 2.9B | 1.8B |
| Operating Expenses | 2.1B | 2.1B | 2.0B | 2.0B | 1.4B |
| Operating Income | 671.8M | 656.7M | 654.0M | 976.4M | 387.2M |
| Pre-tax Income | 609.0M | 641.2M | 599.1M | 1.0B | 378.9M |
| Income Tax | 187.6M | 196.2M | 237.5M | 240.4M | -1.4B |
| Net Income | 421.4M | 445.1M | 361.6M | 772.0M | 1.8B |
| EPS (Diluted) | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 |
Income Statement Trend
Align Technology Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 2.5B | 2.4B | 2.4B | 2.5B | 1.8B |
| Non-Current Assets | 3.7B | 3.6B | 3.5B | 3.4B | 3.0B |
| Total Assets | 6.2B | 6.1B | 5.9B | 5.9B | 4.8B |
| Liabilities | |||||
| Current Liabilities | 2.0B | 2.1B | 1.9B | 1.9B | 1.3B |
| Non-Current Liabilities | 324.6M | 386.8M | 420.7M | 395.3M | 270.2M |
| Total Liabilities | 2.4B | 2.5B | 2.3B | 2.3B | 1.6B |
| Equity | |||||
| Total Shareholders Equity | 3.9B | 3.6B | 3.6B | 3.6B | 3.2B |
Balance Sheet Composition
Align Technology Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 421.4M | 445.1M | 361.6M | 772.0M | 1.8B |
| Operating Cash Flow | 607.2M | 793.2M | 749.9M | 1.2B | 643.9M |
| Investing Activities | |||||
| Capital Expenditures | -115.6M | -177.7M | -291.9M | -401.1M | -154.9M |
| Investing Cash Flow | -254.9M | -195.9M | -213.3M | -563.4M | -231.5M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -355.7M | -598.3M | -501.7M | -458.3M | -30.8M |
| Free Cash Flow | 622.7M | 608.1M | 276.8M | 771.4M | 507.3M |
Cash Flow Trend
Align Technology Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.99
Forward P/E
17.72
Price to Book
3.50
Price to Sales
3.31
PEG Ratio
17.72
Profitability Ratios
Profit Margin
10.29%
Operating Margin
14.02%
Return on Equity
10.84%
Return on Assets
6.72%
Financial Health
Current Ratio
1.21
Debt to Equity
3.12
Beta
1.64
Per Share Data
EPS (TTM)
$5.51
Book Value per Share
$51.94
Revenue per Share
$53.45
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| algn | 13.2B | 32.99 | 3.50 | 10.84% | 10.29% | 3.12 |
| Intuitive Surgical | 184.6B | 75.42 | 10.79 | 15.96% | 28.41% | 0.00 |
| Becton, Dickinson | 48.6B | 32.89 | 1.93 | 5.89% | 7.18% | 76.34 |
| Alcon | 42.8B | 38.45 | 1.95 | 5.23% | 11.28% | 23.63 |
| ResMed | 37.3B | 28.60 | 6.73 | 25.81% | 26.15% | 15.14 |
| West Pharmaceutical | 16.0B | 34.96 | 5.96 | 17.42% | 16.13% | 11.46 |
Financial data is updated regularly. All figures are in the company's reporting currency.